본문 바로가기
KERD
논문KCI 등재

신생아 Bartter 증후군 1례

A Case of Neonatal Bartter Syndrome

0

조회

0

다운로드

1

인용

0

참고문헌

주제분류소아과학

초록

신생아 Bartter 증후군 환아를 조기에 진단하고 조기에 치료하는 것은 정상 성장과 발달을 얻을 수 있을 뿐만 아니라, 고칼슘뇨증과 신석회화의 진행을 막고 만성신부전으로의 이행을 예방할 수 있어 중요하다. 이에 저자들은 생후 6개월에 진단하고 인도메타신과 경구칼륨투여로 증상의 호전을 보인 신생아 Bartter 증후군 1례를 보고하는 바이다.

Abstract

Bartter and Bartter-like syndromes, which include classic Bartter syndrome(type III), neonatal Bartter syndrome(type I, II or IV) and Gitelman syndrome, are autosomal - recessively inherited renal tubular disorders characterized by hypokalemic metabolic alkalosis, salt wasting and normal to low blood pressure. Neonatal Bartter syndrome is characterized by intrauterine polyhydramnios, premature delivery, life-threatening episodes of fever and dehydration, subsequent failure to thrive, and severe hypercalciuria with nephrocalcinosis and osteopenia. It is caused by mutations in NKCC2(type I), ROMK(type II) or BSND(type IV) genes. If diagnosed and treated early, the progression to renal failure can be prevented and catch-up growth and normal development are achieved. We report here a 6 month-old infant with neonatal Bartter syndrome who presented with hypokalemic metabolic alkalosis, polyhydramnios and premature delivery, persistent high fever and dehydration, failure to thrive, hypercalciuria, and nephrocalcinosis. He received indomethacin and potassium chloride per os and showed catch-up growth and normal developmental profile at 19 months of age.

참고문헌 (32)

  1. "Hyperplasia of juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis", 33, pp.811~28 (1962)
  2. "Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders", 1, pp.491~7 (1987)
  3. "Congenital hypokalemia with hypercalciuria in preterm infants:a hyperprostaglandinuric tubular syndrome different from Bartter syndrome", 107, pp.694~701 (1985)
  4. "Bartter and related syndromes:the puzzle is almost solved", 12, pp.315~27 (1998)
  5. "Prenatal diagnosis in Bartter syndrome", 1, pp.394~ (1987)
  6. "Infantile variant of Bartter syndrome and sensorineural deafness:a new autosomal recessive disorder", 59, pp.454~9 (1995)
  7. "Bartter syndrome in Costa Rica:a description of 20 cases", 11, pp.296~301 (1997)
  8. "Bartter syndrome:typical facies and normal plasma volume", 129, pp.1205~7 (1975)
  9. "Pre- and postnatal diagnosis of hyperprostaglandin E syndrome following molecular diagnosis from amniocytes", 8, pp.90~ (1997)
  10. "Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure", 29, pp.310~4 (2001)
  11. "Atypical cases of the hypercalciuric variant of Bartter syndrome:importance of molecular diagnosis", 11, pp.49~ (1997)
  12. "Bartter's syndrome,hypokalaemic alkalosis with hypercalciuria,is caused by mutations in the Na-K-2Cl cotransporter NKCC2", 13, pp.183~8 (1996)
  13. "An extreme example of the neonatal form of Bartter's syndrome", 10, pp.496~7 (1996)
  14. "The role of cyclooxygenases in furosemide-like salt losing the hyperprostaglandin E syndrome Acta Physiol Scand 2004", 181, pp.523~8 (2004)
  15. "Vasoactive peptides in Bartter's syndrome", 23, pp.80~3 (1993)
  16. "Hypokalemia and prostaglandin overproduction in Bartter's syndrome", 37, pp.257~63 (1984)
  17. "Bartter's syndrome with hyperplasia of renomedullary cells", 9, pp.302~7 (1976)
  18. "Hypercalciuria with Bartter syndrome:evidence for an abnormality of vitamin D metabolism", 115, pp.397~404 (1989)
  19. "Prostaglandin synthetase inhibitors in Bartter's syndrome:effect on immunoreactive prostaglandin E excretion", 239, pp.117~21 (1978)
  20. "Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome", 2, pp.205~9 (1988)
  21. "Pre-pubertal growth in the hyperprostaglandin E syndrome", 9, pp.729~33 (1995)
  22. "Bartter's syndrome,A disorder characterised by high urinary prostaglandins and a dependence of hyperreninaemia on prostaglandin synthesis", 61, pp.43~51 (1976)
  23. "Bartter's syndrome:10 cases in childhood", 191, pp.429~46
  24. "Hypercalciuric Bartter syndrome:resolution of nephrocalcinosis with indomethacin", 152, pp.1251~3 (1989)
  25. "Indomethacin therapy in preterm neonates with patent ductus arteriosus", 27, pp.370~5 (1991)
  26. "Localised intestinal perforations after enteral administration of indomethacin in premature infants", 106, pp.277~81 (1985)
  27. "Effect of age and birth weight on indomethacin pharmacodynamics in neonates treated for patent ductus arteriosus", 30, pp.343~8 (2002)
  28. "Indomethacin and renal impairment in neonates", 19, pp.490~3 (2004)
  29. "Bartter syndrome:benefits and side effects of long-term treatment", 19, pp.858~63 (2004)
  30. "Successful management of an extreme example of neonatal hyperprostaglandin-E syndrome(Bartter's syndrome)with the new cyclooxygenase-2 inhibitor rofecoxib", 4, pp.249~51 (2003)
  31. "Steady-state plasma concentrations of rofecoxib in children(ages 2-5 years) with juvenile rheumatoid arthritis(JRA). Arthritis Rheum", 44, pp.291~ (2001)
  32. "Role of cyclooxigenase-2 in hyperprostaglandin E syndrome", antenatal Bartter symdrome, 2002, pp.62, 253~60

관련 논문AI추천

이 간행물의 다른 논문 (20건)